Treatment of Colorectal Cancer
Colorectal cancer develops in the colon or rectum and is the third most common cancer globally. Risk factors include age over 50, family history, inflammatory bowel disease, and diet high in red/processed meat.
Managing Colorectal Cancer effectively requires a combination of medical treatment, lifestyle modification, and regular monitoring. With a structured management plan, most people with Colorectal Cancer can maintain a good quality of life and prevent serious complications.
First-Line Treatment Principles
- ✓Multidisciplinary team (MDT) approach: oncology, surgery, radiotherapy, pathology, palliative care
- ✓Stage-appropriate intent: curative vs. palliative — informs treatment intensity and goals
- ✓Systemic therapy: chemotherapy, targeted therapy, immunotherapy (checkpoint inhibitors), hormone therapy
- ✓Surgical resection: primary curative approach for solid tumours when localised
- ✓Radiotherapy: definitive, adjuvant, or palliative depending on tumour type and stage
What to Do Now
- Learn your personal risk factors for Colorectal Cancer (family history, age, lifestyle)
- Attend regular health check-ups and screening tests appropriate for your age and risk
- Track new or changing symptoms, especially those associated with Colorectal Cancer
- Use our AI symptom checker to assess whether your symptoms fit an early Colorectal Cancer pattern
- Discuss preventive strategies and early monitoring with your GP
- Build a personalised management plan with your GP or specialist
- Adhere consistently to prescribed medications — do not stop without medical advice
- Adopt a Colorectal Cancer-appropriate diet (anti-inflammatory, low-glycaemic, or disease-specific)
Medications Used in Colorectal Cancer
Capecitabine is a cytotoxic chemotherapy agent that kills rapidly dividing cancer cells, used in a variety of malignancies.
Cyclophosphamide is a cytotoxic chemotherapy agent that kills rapidly dividing cancer cells, used in a variety of malignancies.
Fluorouracil is a cytotoxic chemotherapy agent that kills rapidly dividing cancer cells, used in a variety of malignancies.
Paclitaxel is a cytotoxic chemotherapy agent that kills rapidly dividing cancer cells, used in a variety of malignancies.
Carboplatin is a cytotoxic chemotherapy agent that kills rapidly dividing cancer cells, used in a variety of malignancies.
Hydroxyurea is a cytotoxic chemotherapy agent that kills rapidly dividing cancer cells, used in a variety of malignancies.
Trastuzumab is a monoclonal antibody used in oncology to target cancer-specific antigens and disrupt tumor growth or vascularization.
Bevacizumab is a monoclonal antibody used in oncology to target cancer-specific antigens and disrupt tumor growth or vascularization.
Non-Pharmacological Management
- •Nutritional support: maintain weight and muscle mass; dietitian involvement
- •Physiotherapy and exercise oncology: reduced fatigue, improved outcomes
- •Psychological support: validated cancer-specific interventions (CBT, supportive psychotherapy)
- •Smoking cessation and alcohol reduction: reduces treatment toxicity and second primary cancers
- •Palliative care integration from diagnosis: symptom management, advance care planning
- •Fertility preservation: discuss before gonadotoxic therapy in reproductive age patients
- •Sun protection post-treatment: radiation-sensitised skin; immunosuppressed skin cancer risk
Treatment Goals
Monitoring Parameters
- ◆Tumour markers: PSA (prostate), CA-125 (ovarian), CEA (colorectal), AFP (liver) — at defined intervals
- ◆Imaging: CT/MRI/PET per tumour-specific response criteria (RECIST)
- ◆FBC: myelosuppression monitoring during chemotherapy — weekly during active treatment
- ◆Cardiotoxicity: LVEF monitoring with anthracyclines and trastuzumab (echo before, during, after)
- ◆Renal and hepatic function: before each chemotherapy cycle; drug dose adjustments
- ◆Peripheral neuropathy grading: platinum and taxane-based regimens
Red Flags — When to Escalate
- ⚠Any of the characteristic symptoms of Colorectal Cancer — even mild — in a high-risk individual
- ⚠Progressive worsening of early warning signs over weeks
- ⚠Laboratory abnormalities (e.g., blood sugar, inflammatory markers) without full symptoms
- ⚠Unexplained weight loss, night sweats, or fatigue persisting >2 weeks
- ⚠Strong family history of Colorectal Cancer combined with new relevant symptoms
- ⚠Sudden worsening of Colorectal Cancer symptoms despite established treatment
Escalation Criteria
- →Febrile neutropenia: broad-spectrum IV antibiotics within 1 hour of presentation; emergency
- →Progressive disease on first-line treatment → second-line regimen; clinical trial consideration
- →Oncological emergencies: spinal cord compression, SVC syndrome, tumour lysis syndrome → urgent oncology review
- →Deteriorating performance status → reassess treatment goals; palliative focus
Special Populations
Clinical Insights
Compare With Similar Conditions
Not sure about your symptoms?
Our AI Symptom Checker analyses your symptoms and suggests the most likely diagnoses — including relevant treatment pathways.
Use AI Symptom Checker →